CDEK
← Mechanisms of action

epstein-barr virus

ORGANISMHomo sapiens

Drugs acting on this target (16)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
ebv gh/gl/gp42-ferritin nanoparticle vaccineImmunity, activeexperimentalVaccineepstein-barr virus immunity, active
ebv mrna vaccineImmunity, activeexperimentalVaccineepstein-barr virus immunity, active
mrna-1195Immunity, activeexperimentalVaccineepstein-barr virus immunity, active
wgc-043Immunity, activeexperimentalVaccineepstein-barr virus immunity, active
EBV Specific T-LymphocytesImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
ebv tscm ctlImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
ebv-tcr-t cellsImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
ebvint cellImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
epstein-barr virus cytotoxic t lymphocytesImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
multivirus specific t cellsImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
pentavalent-specific t cells (penta-sts)Immunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
PosoleucelImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
tgfbeta resistant lmp-specific ctlsImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
tri-virus specific cytotoxic t-cellsImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
virus-specific T cellsImmunity, passiveexperimentalCell therapyepstein-barr virus immunity, passive
ksd-101InhibitorexperimentalSmall moleculeepstein-barr virus inhibitor